Abstract
Surgery remains the standard treatment for localized non-small cell lung cancer while the local control is optimal. For some patients, surgery is impossible due to comorbidities, especially in case of severe COPD. Stereotactic radiation is then a good option for these localized lung tumors without any nodes involvement. Peripheral lesions, but also central tumors can be treated providing less hypofractionated treatment. Due to hypofraction as well as its high precision, stereotactic radiation offers both a high quality of treatment and a well-tolerated treatment. Local control is high (> 80 %) and complications are limited. In contrast, survival data remain quite poor while patients die frequently of comorbidities or from metastatic progression.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
